NL-OMON40686已完成不适用
Assessment of Bone Material Strength by Microindentation in vivo in Patients with Acromegaly - BMS in Acromegaly
Endocrinologie0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •patients with Acromegaly and
- •Age above 18 years
- •Available data on acromegalic disease, tumor characteristics
- •Stable hormone situation for 3 months
排除标准
- •Active infection of the measurement site.
- •Recent fracture of the tibia.
- •Underlying metabolic bone disease, including vitamin D deficiency.
- •Untreated hypogonadism
研究者
相似试验
招募中
不适用
Assessment of Bone Material Strength by Microindentation in vivo after Fracture or Surgery-related ImmobilizatioNL-OMON43556eids Universitair Medisch Centrum42
进行中（未招募）
1 期
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboOsteoporosis is a systemic skeletal disorder characterized by low bone mass and micro-architectural deterioration of bone tissue leading to enhanced bone fragility and susceptibility to fracture. Postmenopausal women with a diagnosis of osteopenia (T score between –2.5 and –1.0 based on the World Health Organization classification) may also be at risk of fracture.MedDRA version: 7.0 Level: PT Classification code 10031285EUCTR2005-003033-41-GBProcter & Gamble Technical Centres Limited156
进行中（未招募）
不适用
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboEUCTR2005-003033-41-DEProcter & Gamble Technical Centres Limited156
已完成
4 期
Prospective evaluation of bone strength, physical activity, falls, subsequent fractures and mortality in patients presenting with a recent clinical fracture.loss of bone mass1001329610017322NL-OMON41637Viecuri Medisch Centrum voor Noord-Limburg500
招募中
不适用
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritisDRKS00021182Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin60